Literature DB >> 23695876

Key factors influencing prognosis in relation to gallbladder cancer.

Charles Henry Caldow Pilgrim1, Ryan T Groeschl, Kiran K Turaga, T Clark Gamblin.   

Abstract

INTRODUCTION: The 5-year survival of patients with gallbladder cancer remains low. However, patients can be stratified into prognostic categories based on established factors such as T, N, and R status. New concepts regarding prognostic significance of lymph node disease, the importance of residual gallbladder fossa disease, and the gravity of presentation with jaundice are reviewed. In addition, a number of new prognostic factors proposed in recent years are considered.
METHODS: PubMed was searched for "gallbladder cancer" with builder "date-completion" 2008 to present. A total of 1,490 articles were screened from which 168 were retrieved. From this, 40 articles specifically related to prognosis form the basis for this review. DISCUSSION: Key factors of prognostic significance remain T and N stage and R0 resection. Residual disease either in the gallbladder fossa, lymph nodes, or cystic duct margin dictates hepatectomy, lymphadenectomy and bile duct resection, respectively. Adequate lymphadenectomy requires removal of six nodes, and hepatectomy must be sufficient to achieve R0. Subtleties regarding lymph node ratio, significance of pathological features such as dedifferentiation, and budding may hold value for stratifying patients with early stage disease, but require further investigation.

Entities:  

Mesh:

Year:  2013        PMID: 23695876     DOI: 10.1007/s10620-013-2713-y

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  42 in total

1.  Gallbladder cancer: differences in presentation, surgical treatment, and survival in patients treated at centers in three countries.

Authors:  Jean M Butte; Kenichi Matsuo; Mithat Gönen; Michael I D'Angelica; Enrique Waugh; Peter J Allen; Yuman Fong; Ronald P DeMatteo; Leslie Blumgart; Itaru Endo; Hernán De La Fuente; William R Jarnagin
Journal:  J Am Coll Surg       Date:  2010-11-12       Impact factor: 6.113

2.  Biology dictates prognosis following resection of gallbladder carcinoma: sometimes less is more.

Authors:  Timothy M Pawlik; Michael A Choti
Journal:  Ann Surg Oncol       Date:  2009-01-23       Impact factor: 5.344

3.  Prognostic factors of patients with advanced gallbladder carcinoma following aggressive surgical resection.

Authors:  Yoshiaki Murakami; Kenichiro Uemura; Takeshi Sudo; Yasushi Hashimoto; Akira Nakashima; Naru Kondo; Ryutaro Sakabe; Hironori Kobayashi; Taijiro Sueda
Journal:  J Gastrointest Surg       Date:  2011-03-10       Impact factor: 3.452

4.  Accurate staging for gallbladder cancer: implications for surgical therapy and pathological assessment.

Authors:  Hiromichi Ito; Kaori Ito; Michael D'Angelica; Mithat Gonen; David Klimstra; Peter Allen; Ronald P DeMatteo; Yuman Fong; Leslie H Blumgart; William R Jarnagin
Journal:  Ann Surg       Date:  2011-08       Impact factor: 12.969

5.  Is port site resection necessary in the surgical management of gallbladder cancer?

Authors:  Ajay V Maker; Jean M Butte; Jacqueline Oxenberg; Deborah Kuk; Mithat Gonen; Yuman Fong; Ronald P Dematteo; Michael I D'Angelica; Peter J Allen; William R Jarnagin
Journal:  Ann Surg Oncol       Date:  2011-06-23       Impact factor: 5.344

Review 6.  Long-term results after resection for gallbladder cancer. Implications for staging and management.

Authors:  D L Bartlett; Y Fong; J G Fortner; M F Brennan; L H Blumgart
Journal:  Ann Surg       Date:  1996-11       Impact factor: 12.969

7.  Is lymph-node micrometastasis in gallbladder cancer a significant prognostic factor?

Authors:  Mikiko Tanabe; Itaru Endo; Hideki Masunari; Mitsutaka Sugita; Daisuke Morioka; Takashi Ishikawa; Yasushi Ichikawa; Hiroshi Shimada
Journal:  Hepatogastroenterology       Date:  2012 Jan-Feb

8.  Number of positive lymph nodes independently determines the prognosis after resection in patients with gallbladder carcinoma.

Authors:  Jun Sakata; Yoshio Shirai; Toshifumi Wakai; Yoichi Ajioka; Katsuyoshi Hatakeyama
Journal:  Ann Surg Oncol       Date:  2010-01-15       Impact factor: 5.344

9.  Surgical outcomes and prognostic factors for T2 gallbladder cancer following surgical resection.

Authors:  Sae Byeol Choi; Hyung Joon Han; Chung Yun Kim; Wan Bae Kim; Tae-Jin Song; Sung Ock Suh; Young Chul Kim; Sang Yong Choi
Journal:  J Gastrointest Surg       Date:  2009-12-22       Impact factor: 3.452

10.  Assessment of lymph node status in gallbladder cancer: location, number, or ratio of positive nodes.

Authors:  Yoshio Shirai; Jun Sakata; Toshifumi Wakai; Taku Ohashi; Yoichi Ajioka; Katsuyoshi Hatakeyama
Journal:  World J Surg Oncol       Date:  2012-05-17       Impact factor: 2.754

View more
  10 in total

1.  Tumor location is a strong predictor of tumor progression and survival in T2 gallbladder cancer: an international multicenter study.

Authors:  Junichi Shindoh; Xabier de Aretxabala; Thomas A Aloia; Juan Carlos Roa; Ivan Roa; Giuseppe Zimmitti; Milind Javle; Claudius Conrad; Dipen M Maru; Taku Aoki; Luca Vigano; Dario Ribero; Norihiro Kokudo; Lorenzo Capussotti; Jean-Nicolas Vauthey
Journal:  Ann Surg       Date:  2015-04       Impact factor: 12.969

2.  Benefit of extended radical surgery for incidental gallbladder carcinoma.

Authors:  Junpei Yamaguchi; Yuji Kaneoka; Atsuyuki Maeda; Yuichi Takayama; Shunsuke Onoe; Masatoshi Isogai
Journal:  Surg Today       Date:  2015-06-17       Impact factor: 2.549

3.  Gallbladder Carcinoma, the Difficulty of Early Detection: A Case Report.

Authors:  Andrew E Graff; Stephen L Lewis; Jonathan R Bear; David C Van Echo; Hugh M Dainer
Journal:  Cureus       Date:  2016-02-12

4.  Prognostic Implications of Lymph Node Status for Patients With Gallbladder Cancer: A Multi-Institutional Study.

Authors:  Neda Amini; Yuhree Kim; Ana Wilson; Georgios Antonios Margonis; Cecilia G Ethun; George Poultsides; Thuy Tran; Kamran Idrees; Chelsea A Isom; Ryan C Fields; Bradley Krasnick; Sharon M Weber; Ahmed Salem; Robert C G Martin; Charles Scoggins; Perry Shen; Harveshp D Mogal; Carl Schmidt; Eliza Beal; Ioannis Hatzaras; Rivfka Shenoy; Shishir K Maithel; Timothy M Pawlik
Journal:  Ann Surg Oncol       Date:  2016-05-05       Impact factor: 5.344

5.  Platelet to lymphocyte ratio as a novel prognostic tool for gallbladder carcinoma.

Authors:  Qing Pang; Ling-Qiang Zhang; Rui-Tao Wang; Jian-Bin Bi; Jing-Yao Zhang; Kai Qu; Su-Shun Liu; Si-Dong Song; Xin-Sen Xu; Zhi-Xin Wang; Chang Liu
Journal:  World J Gastroenterol       Date:  2015-06-07       Impact factor: 5.742

6.  Preoperative CT findings for prediction of resectability in patients with gallbladder cancer.

Authors:  Seo-Youn Choi; Jung Hoon Kim; Hyun Jeong Park; Joon Koo Han
Journal:  Eur Radiol       Date:  2019-06-28       Impact factor: 5.315

7.  Serum CYFRA 21-1 in Biliary Tract Cancers: A Reliable Biomarker for Gallbladder Carcinoma and Intrahepatic Cholangiocarcinoma.

Authors:  Li Huang; Wei Chen; Peiwen Liang; Wenjie Hu; Kunsong Zhang; Shunli Shen; Jiancong Chen; Zhaohui Zhang; Bin Chen; Yuyan Han; Fanyin Meng; Sharon DeMorrow; Xiaoyu Yin; Jiaming Lai; Lijian Liang
Journal:  Dig Dis Sci       Date:  2014-12-09       Impact factor: 3.199

8.  Lymph node status after resection for gallbladder adenocarcinoma: prognostic implications of different nodal staging/scoring systems.

Authors:  Neda Amini; Gaya Spolverato; Yuhree Kim; Rohan Gupta; Georgios Antonios Margonis; Aslam Ejaz; Timothy M Pawlik
Journal:  J Surg Oncol       Date:  2014-10-13       Impact factor: 3.454

Review 9.  Surgical treatment of gallbladder carcinoma: a critical review.

Authors:  Farzad Kakaei; Samad Beheshtirouy; Seyed Mohammadreza Nejatollahi; Sina Zarrintan; Mohammad Reza Mafi
Journal:  Updates Surg       Date:  2015-11-12

10.  Clinicopathological features of gallbladder papillary adenocarcinoma.

Authors:  Xueshuai Wan; Haohai Zhang; Cuimin Chen; Xiaobo Yang; Anqiang Wang; Chengpei Zhu; Lilan Fu; Ruoyu Miao; Lian He; Huayu Yang; Haitao Zhao; Xinting Sang
Journal:  Medicine (Baltimore)       Date:  2014-12       Impact factor: 1.889

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.